Opportunity Information: Apply for CDC RFA GH17 1774
Apply for CDC RFA GH17 1774
- The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Building the Capacity of the Government of Suriname to Address Gaps in the HIV Continuum of Care for Key Populations and People Living with HIV (PLHIV) under the President's Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Aug 05, 2016.
- Applicants must submit their applications by Oct 04, 2016 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $300,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity is a CDC Caribbean Regional Office (CDC CRO) cooperative agreement under PEPFAR focused on strengthening the Government of Suriname's ability to close gaps across the HIV continuum of prevention, care, and treatment. The overarching public health aim aligns with CDC CRO's regional mission to reduce HIV transmission in the Caribbean by improving how countries find people with HIV earlier, connect them to services faster, keep them engaged in care, and expand access to effective treatment so viral suppression increases at the population level.
The program is centered on practical improvements to the continuum of care for two main groups: key populations at elevated risk of acquiring or transmitting HIV, and people living with HIV (PLHIV). A major emphasis is on prevention and early diagnosis, meaning the work is expected to strengthen approaches that identify undiagnosed infections sooner and reduce delays between a positive test and entry into clinical care. Once individuals are diagnosed, the opportunity prioritizes better linkage to care and stronger retention strategies, recognizing that drop-off between diagnosis, treatment initiation, and long-term engagement is a common driver of ongoing transmission and worse health outcomes.
A core treatment priority highlighted in the announcement is the rollout or expansion of "Test and Start," the approach that initiates antiretroviral therapy as soon as possible after diagnosis rather than waiting for disease progression. In practice, this means supporting systems and service delivery changes that increase antiretroviral coverage among eligible PLHIV and reduce barriers to starting treatment quickly. Because sustained treatment and viral suppression are key to both individual health and prevention, the opportunity implicitly supports activities that help programs reach epidemic control benchmarks through improved treatment uptake and continuity.
The announcement also makes clear that strengthening the national laboratory system is a major use of funds. This typically involves improving the quality, reliability, and coverage of laboratory services that underpin HIV programs, such as diagnostics and monitoring tests (for example, viral load testing, where applicable), as well as the logistics and quality management systems that make lab networks function consistently. Building laboratory capacity supports faster, more accurate diagnosis and better clinical monitoring, which are essential for treatment success and for identifying program weaknesses.
Another central pillar is the expansion of strategic information capacity, with an explicit focus on better data collection, analysis, and use. The intent is not simply to gather more data, but to use it to identify where the continuum is breaking down, select interventions that directly address those gaps, and track whether the response is improving over time. The FOA ties this data-driven approach to monitoring progress against internationally recognized performance targets, including UNAIDS 90-90-90 (diagnose 90 percent of all PLHIV, treat 90 percent of those diagnosed, and achieve viral suppression in 90 percent of those treated). This emphasis suggests the award will support surveillance, program monitoring, and analytic capacity that can translate routine program information into actionable decisions.
Administratively, this is a discretionary health funding opportunity issued by the U.S. Department of Health and Human Services through the Centers for Disease Control and Prevention (CDC), cataloged under CFDA 93.067. The funding instrument is a cooperative agreement, which generally indicates substantial federal involvement such as technical collaboration, shared planning, or close monitoring compared to a standard grant. The opportunity anticipated a single award, with a maximum award amount (ceiling) of $300,000. The funding opportunity number is CDC RFA GH17-1774, and the original application deadline was October 4, 2016 (with electronic submissions due by 11:59 p.m. Eastern Time on the due date). Eligibility is listed broadly as "Others," with details referenced in the full announcement's eligibility section.
Overall, the opportunity is designed to help Suriname strengthen the systems that make an HIV response work end-to-end: targeted prevention and testing for key populations, rapid linkage and durable retention for PLHIV, faster treatment initiation through Test and Start, better laboratory services to support diagnosis and monitoring, and stronger strategic information so the national program can continuously identify gaps, deploy solutions, and measure progress toward 90-90-90.
Frequently Asked Questions (FAQs)
What is this funding opportunity?
This opportunity is a CDC Caribbean Regional Office (CDC CRO) cooperative agreement under PEPFAR focused on strengthening the Government of Suriname's ability to close gaps across the HIV continuum of prevention, care, and treatment.
What is the main public health goal of the award?
The overarching aim aligns with CDC CRO's regional mission to reduce HIV transmission in the Caribbean by improving how countries identify people with HIV earlier, link them to services faster, keep them engaged in care, and expand access to effective treatment so viral suppression increases at the population level.
Which country is the work intended to support?
The program is specifically intended to strengthen the Government of Suriname's capacity to improve HIV prevention, diagnosis, care, and treatment systems.
Who are the primary populations of focus?
The work is centered on practical improvements for two main groups: (1) key populations at elevated risk of acquiring or transmitting HIV, and (2) people living with HIV (PLHIV).
What parts of the HIV continuum are emphasized?
The announcement emphasizes prevention and early diagnosis, rapid linkage to clinical care after a positive test, stronger retention in care over time, and expanded access to effective treatment to improve viral suppression.
What does the opportunity prioritize for prevention and early diagnosis?
It prioritizes strengthening approaches that identify undiagnosed HIV infections sooner and reducing delays between a positive test and entry into clinical care.
Why is linkage to care a priority in this program?
The opportunity highlights that drop-off between diagnosis, treatment initiation, and long-term engagement is a common driver of ongoing transmission and worse health outcomes. As a result, it prioritizes better linkage processes and stronger retention strategies.
What does “Test and Start†mean in this announcement?
“Test and Start†refers to initiating antiretroviral therapy as soon as possible after an HIV diagnosis rather than waiting for disease progression.
How is “Test and Start†expected to be supported?
The announcement points to supporting systems and service delivery changes that increase antiretroviral coverage among eligible PLHIV and reduce barriers to starting treatment quickly after diagnosis.
How does treatment and viral suppression fit into the grant’s intent?
Sustained treatment and viral suppression are framed as essential for individual health and prevention. The opportunity is oriented toward improving treatment uptake and continuity to help move toward epidemic control benchmarks.
Is strengthening laboratory services included in the scope?
Yes. Strengthening the national laboratory system is described as a major use of funds.
What kinds of laboratory improvements are contemplated?
The announcement describes improving the quality, reliability, and coverage of laboratory services that underpin HIV programs, including diagnostics and monitoring tests (such as viral load testing, where applicable), as well as logistics and quality management systems needed for consistent lab network performance.
Why does the opportunity emphasize laboratory system strengthening?
Laboratory capacity supports faster, more accurate diagnosis and better clinical monitoring, which are essential for treatment success and for identifying program weaknesses.
What is meant by “strategic information capacity†in this opportunity?
Strategic information capacity refers to improved data collection, analysis, and use so the program can identify where the HIV continuum is breaking down, choose interventions that address those gaps, and track whether the response improves over time.
Is the focus only on collecting more data?
No. The intent described is to use data to drive decisions, target interventions to specific continuum gaps, and monitor progress over time.
Are there specific performance targets mentioned?
Yes. The opportunity references monitoring progress against internationally recognized performance targets, including UNAIDS 90-90-90 (diagnose 90 percent of all PLHIV, treat 90 percent of those diagnosed, and achieve viral suppression in 90 percent of those treated).
Which U.S. agency issues this funding opportunity?
It is issued by the U.S. Department of Health and Human Services through the Centers for Disease Control and Prevention (CDC).
What is the CFDA number associated with this opportunity?
The announcement lists CFDA 93.067.
What type of funding instrument is used?
The funding instrument is a cooperative agreement.
What does a cooperative agreement imply for how the award is managed?
As described, a cooperative agreement generally indicates substantial federal involvement, such as technical collaboration, shared planning, or close monitoring compared to a standard grant.
How many awards were anticipated?
The opportunity anticipated a single award.
What is the maximum award amount?
The maximum (ceiling) award amount is $300,000.
What is the funding opportunity number?
The funding opportunity number is CDC RFA GH17-1774.
What was the application deadline?
The original application deadline was October 4, 2016, with electronic submissions due by 11:59 p.m. Eastern Time on the due date.
Who is eligible to apply based on the information provided?
Eligibility is listed broadly as “Others,†with additional details referenced as being in the full announcement’s eligibility section.
What are the main program pillars described in the announcement?
The announcement describes an end-to-end approach that includes targeted prevention and testing for key populations, rapid linkage and durable retention for PLHIV, faster treatment initiation through Test and Start, strengthened laboratory services for diagnosis and monitoring, and stronger strategic information capacity to identify gaps and measure progress toward 90-90-90.
Browse more opportunities from the same agency: Department of Health and Human Services, Centers for Disease Control - CGH
Browse more opportunities from the same category: Health
Next opportunity: Program Expansion Supplement for Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs in South Africa under PEPFAR
Previous opportunity: Re-announcment of the Community Training and Video Production for Walrus Haulout Public Education Video
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH17 1774
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH17 1774) also looked into and applied for these:
| Funding Opportunity |
|---|
| Program Expansion Supplement for Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs in South Africa under PEPFAR Apply for CDC RFA GH11 11520501SUPP16 Funding Number: CDC RFA GH11 11520501SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $3,604,705 |
| Supporting Local Indigenous Faith-Based Partners in Providing High Quality HIV Care, Prevention and Treatment Services and Improving Linkage and Retention in the Republic of Guyana under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1721 Funding Number: CDC RFA GH17 1721 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $465,000 |
| Support for Quality Facility and Community-based Antiretroviral Therapy (ART) for Adults and Children in Cameroon under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1718 Funding Number: CDC RFA GH17 1718 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $10,000,000 |
| Strengthening Care and Support Services for Highly Vulnerable Populations, Orphans and Vulnerable Children and their Families, plus HIV Prevention for Youth in the Republic of Cote d'Ivoire under PEPFAR Apply for CDC RFA GH17 1755 Funding Number: CDC RFA GH17 1755 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $18,000,000 |
| Projecto de Saúde Para Todos (Health for All, or HFA) Apply for NFO RFA 654 16 000004 Funding Number: NFO RFA 654 16 000004 Agency: Agency for International Development, South Africa USAID-Pretoria Category: Health Funding Amount: $63,000,000 |
| Program Expansion Supplement: Scaling up Voluntary Medical Male Circumcision through improvement in HIV prevention under PEPFAR Apply for CDC RFA GH13 13280401SUPP16 Funding Number: CDC RFA GH13 13280401SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $3,000,000 |
| Human Heredity and Health in Africa (H3Africa): Coordinating Center (U24) Apply for RFA RM 16 017 Funding Number: RFA RM 16 017 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $400,000 |
| Human Heredity and Health in Africa (H3Africa): Informatics Network (U24) Apply for RFA RM 16 011 Funding Number: RFA RM 16 011 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $2,500,000 |
| Vector Control Strategies- Enhancing Capacity for Vector Surveillance and Control to Prevent Zika, Dengue and Chikungunya Infection in Puerto Rico - Financed in part by Prevention and Public Health Funds Apply for CDC RFA CK16 1608PPHF2016 Funding Number: CDC RFA CK16 1608PPHF2016 Agency: Department of Health and Human Services, Centers for Disease Control - NCEZID Category: Health Funding Amount: Case Dependent |
| Addressing Ebola and other Highly Infectious Diseases Internationally Apply for CDC RFA CK15 15050104SUPP16 Funding Number: CDC RFA CK15 15050104SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - NCEZID Category: Health Funding Amount: Case Dependent |
| Assist the Ministry of Health to Provide Critical Human Resources for Health to Achieve HIV Epidemic Control in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1715 Funding Number: CDC RFA GH17 1715 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $900,000 |
| Support for the National Blood Bank Services in the Implementation and Expansion of Blood Safety Activities in Ethiopia under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1746 Funding Number: CDC RFA GH17 1746 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,650,000 |
| Strengthening Capacity of HIV/AIDS Treatment in Ukraine under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1761 Funding Number: CDC RFA GH17 1761 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,600,000 |
| Enhancing Sustainable and Integrated Health, Strategic Information and Laboratory Systems for Quality Comprehensive HIV Services through Technical Assistance to the Republic of Rwanda under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1750 Funding Number: CDC RFA GH17 1750 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $720,000 |
| Strengthening Local Ownership and Sustainable Provision of Quality Comprehensive HIV/AIDS Services for Inmates in the Federal Prison Administration (FPA) and Regional Prisons of Ethiopia under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1777 Funding Number: CDC RFA GH17 1777 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $500,000 |
| Hypertension Outcomes for T4 REsearch within Lower Middle-Income Countries (Hy-TREC) (U01) Apply for RFA HL 17 014 Funding Number: RFA HL 17 014 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $268,500 |
| USAID’s Improving Nutrition through Community-based Approaches (INCA) Activity Apply for RFA 388 16 000010 Funding Number: RFA 388 16 000010 Agency: Agency for International Development, Bangladesh USAID-Dhaka Category: Health Funding Amount: $4,500,000 |
| Strengthening of Ghana National Health Management Systems in the Areas of Strategic Information Systems and Laboratory Capacity Building under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1732 Funding Number: CDC RFA GH17 1732 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,500,000 |
| Ryan White HIV/AIDS Program Part A HIV Emergency Relief Grant Program Apply for HRSA 17 030 Funding Number: HRSA 17 030 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Family Leadership in Language and Learning (FL3) Apply for HRSA 17 061 Funding Number: HRSA 17 061 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH17 1774", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.